NCT05871164Recruiting
Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency
Source: ClinicalTrials.gov · Last updated 1 Apr 2026
Brief summary (registry, in English)
The purpose of the study is to evaluate the oncological efficacy of pancreatic radiofrequency by the objective response rate (complete and partial responses according to RECIST 1.1.), 5 years after the end of treatment.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 15 May 2023
- Start date
- 12 Jun 2023
- Primary completion date
- May 2030
- Lead sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche
- Diseases
- Pancreatic cancer
- NCT number
- NCT05871164
What you commit to
- Study type: Observational
- Planned participants: 200
- From 12 Jun 2023 to the primary completion date, May 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient with a contraindication to radiofrequency treatment;
- Pregnant or breastfeeding women
Who the study is looking for
- Age ≥ 18 years old;
- Patient to be treated for a pancreatic tumor by ultrasound-guided RF with a fine needle;
- Indication of pancreatic radiofrequency validated in a Multidisciplinary Consultation Meeting;
- Patient able to understand the information related to the study;
- Patient accepting study follow-up visits;
- Patient having been informed and agreeing to participate in the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHI Toulon La Seyne Coordinator of this site? Confirm its status | Toulon | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.